Lv5
1090 积分 2024-03-10 加入
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data
16小时前
已完结
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China
21小时前
已完结
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China. Cephalalgia. 2025 Oct;45(10):3331024251371686
22小时前
已关闭
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2023 Jun;22(6):476-484
23小时前
已完结
新型口服和静脉用截短侧耳素——来法莫林在社区获得性肺炎治疗中的应用价值[J]. 中国感染与化疗杂志,2025,25(2):233-240
4天前
已完结
沙芬酰胺治疗帕金森病的研究进展[J]. 中国药理学通报,2019,35(1):8-11
6天前
已完结
Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025 Mar 5;388:e080952
6天前
已完结
仑卡奈单抗治疗阿尔茨海默病患者的基线特征和短期安全性[J]. 中华老年心脑血管病杂志,2025,27(7):915-919
9天前
已完结
仑卡奈单抗治疗阿尔茨海默病临床研究进展[J]. 中国现代神经疾病杂志,2026,26(2):188-193
9天前
已关闭
儿童肾病综合征水肿的管理[J]. 中国小儿急救医学,2021,28(7):571-575
12天前
已完结
皖公网安备34019202002308
